Abstract
AbstractWe have developed ultra‐small gadolinium oxide (Gd2O3) nanoparticles, which are surface‐doped with manganese oxide (MnO) (abbreviated as Gd2O3@MnO). The surface‐doped nanoparticles ranged from 1 to 2 nm in diameter. They were further coated with hydrophilic biocompatible lactobionic acid. In‐vitro tests of the sample solution indicated clear dose‐dependent contrast enhancements in both T1 and T2 map images, showing that the nanoparticles may be used as both T1 and T2 MRI contrast agents. Their performance as a T1 MRI contrast agent was proved in vivo through T1 MR images of a mouse.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
